Abstract:The transient receptor potential ion channel TRPA1 is expressed by primary afferent nerve fibres, in which it functions as a low-threshold sensor for structurally diverse electrophilic irritants, including small volatile environmental toxicants and endogenous algogenic lipids<sup><a href="/articles/s41586-020-2480-9#ref-CR1">1</a></sup>. TRPA1 is also a 'receptor-operated' channel whose activation downstream of metabotropic receptors elicits inflammatory pain or itch, making it an attractive target for novel analgesic therapies<sup><a href="/articles/s41586-020-2480-9#ref-CR2">2</a></sup>. However, the mechanisms by which TRPA1 recognizes and responds to electrophiles or cytoplasmic second messengers remain unknown. Here we use strutural studies and electrophysiology to show that electrophiles act through a two-step process in which modification of a highly reactive cysteine residue (C621) promotes reorientation of a cytoplasmic loop to enhance nucleophilicity and modification of a nearby cysteine (C665), thereby stabilizing the loop in an activating configuration. These actions modulate two restrictions controlling ion permeation, including widening of the selectivity filter to enhance calcium permeability and opening of a canonical gate at the cytoplasmic end of the pore. We propose a model to explain functional coupling between electrophile action and these control points. We also characterize a calcium-binding pocket that is highly conserved across TRP channel subtypes and accounts for all aspects of calcium-dependent TRPA1 regulation, including potentiation, desensitization and activation by metabotropic receptors. These findings provide a structural framework for understanding how a broad-spectrum irritant receptor is controlled by endogenous and exogenous agents that elicit or exacerbate pain and itch.

An updated patent review of TRPA1 antagonists (2020 – present)

TRPA1 as a drug target--promise and challenges.

De Novo Design of Peptidic Positive Allosteric Modulators Targeting TRPV1 with Analgesic Effects (adv. Sci. 17/2021)

Transient receptor potential ankyrin 1 (TRPA1) modulators: Recent update and future perspective

Molecular basis of TRPA1 regulation in nociceptive neurons. A review

The pharmacology of TRP channels

Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field

Unveiling the role of TRPA1 in cardiovascular health and disease: a mini review

Progress in the development of TRPV1 small-molecule antagonists: Novel Strategies for pain management

Targeting TRP channels for pain relief: A review of current evidence from bench to bedside

Research Progress on TRPA1 in Diseases

Moving towards Supraspinal TRPV1 Receptors for Chronic Pain Relief

De Novo Design of Peptidic Positive Allosteric Modulators Targeting TRPV1 with Analgesic Effects

TRPV1-Targeted Drugs in Development for Human Pain Conditions

Irritant-evoked activation and calcium modulation of the TRPA1 receptor

TRPA1-Related Diseases and Applications of Nanotherapy

The TRPC5 receptor as pharmacological target for pain and metabolic disease

Distinctive Drug Binding Sites and Gating Mechanisms of the Nociceptive Ion Channel TRPA1

Inflammation—the role of TRPA1 channel

Transient receptor potential vanilloid 1 as a therapeutic target in analgesia

Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action Via Cryogenic Electron Microscopy